![Sonnet BioTherapeutics Holdings, Inc. [SONN] posts $5.54M loss as revenue falls 39.98% to $0.0373M](/_next/image?url=http%3A%2F%2F10kinfo-appdata.s3.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FSONN.png&w=3840&q=75)
Sonnet BioTherapeutics Holdings, Inc. [SONN] posts $5.54M loss as revenue falls 39.98% to $0.0373M
By USInMinutes
Published - Feb 14, 2023, 01:45 AM ET
Last Updated - Feb 19, 2023, 01:37 PM EST
| Net Sales: | $0.0373M |
Sonnet BioTherapeutics Holdings, Inc. [SONN] posted a loss of $5.54M, marking a rise of 29.64% for this quarter.
Revenue fell to $0.0373M this quarter compared to $0.0621M in the previous quarter.
According to the latest quarterly report the company has filed with the SEC, current earnings were $-5.54M, up 29.64% from $-7.88M.
The company’s net sales for the period were $0.0373M, down 39.98%. Net sales in the previous quarter were $0.0621M.
